Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.

Autor: Maria Stangou, Smaragdi Marinaki, Evangelos Papachristou, Kyriaki Kolovou, Erasmia Sambani, Synodi Zerbala, Panagiota Papadea, Olga Balafa, Karolos-Pavlos Rapsomanikis, Aimilios Andrikos, Panagiota Manolakaki, Dorothea Papadopoulou, Efstathios Mitsopoulos, Helen Liakou, Paraskevi-Evi Andronikidi, Vasiliki Choulitoudi, George Moustakas, Dimitra Galitsiou, Eugene Dafnis, Kostas Stylianou, Ioannis Stefanidis, Spyridon Golfinopoulos, Stylianos Panagoutsos, Maria Tsilivigkou, Apostolos Papadogianakis, Ioannis Tzanakis, Athanasios Sioulis, Dimitrios Vlachakos, Eirini Grapsa, Sophia Spaia, Nikolaos Kaperonis, Christos Paliouras, Christos Dioudis, Fani Papoulidou, Theofanis Apostolou, Christos Iatrou, Ioannis Boletis, Dimitrios Goumenos, Aikaperini Papagianni

Publikováno v: PLoS ONE, Vol 14, Iss 8, p e0217116 (2019)

IntroductionManagement of the Primary Membranous Nephropathy (PMN) usually involves administration of immunosuppressives. Cyclophosphamide (Cyclo) and Calcineurin Inhibitors (CNIs) are both widely used but only limited data exist to compare their eff

Externí odkaz: https://doaj.org/article/d5348b58e297403cbb505dcc33b6f443

Quality of life of caregivers of end‐stage kidney disease patients: Caregivers or care recipients?

Autor: Evangelia Dounousi, Fani Papoulidou, Vasilios Koutlas, Margarita Ikonomou, Theodore Vassilikopoulos, Stavroula Vovlianou

Publikováno v: Journal of Renal Care. 49:56-72

Background End-stage kidney disease (ESKD) patients require specific and continuous care, which affects caregivers' quality of life (QOL). It is necessary to define the basic problems and restrictions upon family caregivers of renal patients affectin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::392e2820e155350bf4dfc37dc961da17
https://doi.org/10.1111/jorc.12403

Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views

Autor: Pantelis Sarafidis, Charles J. Ferro, Fani Papoulidou, Laura Labriola, Jean-Michel Halimi, Alexandre Persu, Marco Pappaccogli, Olivier Phan, Patrick Saudan, Roberto Bullani, Patrick Rossignol, Eleni Panou, Grégoire Wuerzner, Gérard M. London, Patricia Van der Niepen, Afroditi Avdelidou, Liffert Vogt, Menno Pruijm, Georges Halabi

Publikováno v: Nephrology, dialysis, transplantation, 34(9), 1612-1615. Oxford University Press
Nephrology, dialysis, transplantation, Vol. 34, no. 9, p. 1612-1625 (2019)

Blood pressure (BP) is routinely measured as a vital sign before, during and/or after dialysis (peridialysis BP). Even if peridialytic measurements are widely used, the agreement with the interdialytic BP is poor and is often biased by many technical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0651b82a2de6f2376cf231ed5898b8c1
https://doi.org/10.1093/ndt/gfz125

Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy

Autor: Christos Dioudis, Eirini Grapsa, Smaragdi Marinaki, Dimitrios S. Goumenos, Aimilios Andrikos, Karolos-Pavlos Rapsomanikis, Christos Iatrou, Synodi Zerbala, Athanasios Sioulis, Evangelos Papachristou, Maria Stangou, Ioannis Stefanidis, Ioannis Boletis, Maria Tsilivigkou, Olga Balafa, Nikolaos Kaperonis, Vasiliki Choulitoudi, Ioannis Tzanakis, Sophia Spaia, Apostolos Papadogianakis, Eugene Dafnis, Erasmia Sambani, Fani Papoulidou, Aikaperini Papagianni, Theofanis Apostolou, Dimitrios Vlachakos, Efstathios Mitsopoulos, Panagiota Manolakaki, Paraskevi-Evi Andronikidi, Christos Paliouras, Kyriaki Kolovou, Dorothea Papadopoulou, Stylianos Panagoutsos, Dimitra Galitsiou, Panagiota Papadea, Helen Liakou, Spyridon Golfinopoulos, Kostas Stylianou, George Moustakas

Publikováno v: PLoS ONE, Vol 14, Iss 8, p e0217116 (2019)
PLoS ONE

IntroductionManagement of the Primary Membranous Nephropathy (PMN) usually involves administration of immunosuppressives. Cyclophosphamide (Cyclo) and Calcineurin Inhibitors (CNIs) are both widely used but only limited data exist to compare their eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d27297cd42cc88d81721dda85c2be796
https://doaj.org/article/d5348b58e297403cbb505dcc33b6f443